Cannabis Market Insights: Analyzing EBITDA Projections for Q3:23 and Beyond Cannabis Market Insights: Analyzing EBITDA Projections for Q3:23 and Beyond

Avatar photo

Kicking off the new year with the first wave of 4th Quarter cannabis earnings releases, analysts delve into the anticipated EBITDA figures for twelve major MSOs, painting a vivid picture of what lies ahead.

  • The graph showcases the expected percentage growth in EBITDA from Q4:22 to Q4:23, the sequential quarter percentage growth from Q3:23 to Q4:23, and the projected increase in EBITDA from 2023 to 2024.

  • Noteworthy is the revelation that ten out of the twelve companies display negative sequential quarter growth, sparking curiosity and raising eyebrows within the industry.

  • There is a distinct trend where year-over-year growth is heavily skewed towards the smaller players, adding complexity to the financial landscape as larger companies navigate challenging market dynamics.

  • Shifting focus towards more lucrative markets serves as a pivotal factor in potentially surpassing the expected 2024 results, underpinned by strategic cost-saving measures and prudent investment decisions.

  • Rather than fixating on static estimates, the key lies in monitoring and analyzing earnings estimate revisions to gauge market sentiment accurately, fueling a growing expectation of a promising 2024 outlook.

  • Amidst a backdrop of revised projections and recalibrations, analysts are treading cautiously, haunted by the ghosts of past mispredictions, with hopes that the bar for 2024 isn’t set too low.

The study underscores the vital role of the Viridian Cannabis Deal Tracker in distilling essential investment trends and strategic insights for industry stakeholders.

Unveiling key trends within the cannabis space, the tracker equips companies and investors to navigate the complex terrain of capital allocation and M&A strategy.

  • By categorizing deals by industry sector, deal structure, and geographical locations, the tracker provides a comprehensive view of market dynamics shaping the cannabis landscape.

  • Since its inception, the Viridian Cannabis Deal Tracker has been pivotal in tracking over $50 billion worth of capital raises and M&A transactions, offering unparalleled insights into market movements.

Upcoming Benzinga Cannabis Conferences in Los Angeles

Join the Benzinga Cannabis Market Spotlight: California, and unlock the future of cannabis at the premier networking event in Culver City on February 22. Connect with top industry leaders, gain insider insights into the investment landscape, and shape the evolving markets in California and beyond. Don’t miss this chance to be at the forefront of the cannabis industry’s growth and innovation! Join now.


The free Daily Market Overview 250k traders and investors are reading

Read Now